Literature DB >> 2065254

Neurological disease in xeroderma pigmentosum. Documentation of a late onset type of the juvenile onset form.

J H Robbins1, R A Brumback, M Mendiones, S F Barrett, J R Carl, S Cho, M B Denckla, M B Ganges, L H Gerber, R A Guthrie.   

Abstract

Xeroderma pigmentosum (XP) is an autosomal recessive, neurocutaneous disorder characterized by sunlight-induced skin cancers and defective DNA repair. Many XP children develop a primary neuronal degeneration. We describe 2 unusual XP patients who had a delayed onset of XP neurological disease. Somatic cell genetic studies indicated that they have the same defective DNA repair gene and are both in XP complementation group A. These 2 patients, together with a group A patient previously reported from London, establish as a distinct clinical entity the late onset type of the juvenile onset form of XP neurological disease. The functional capacity of these patients' cultured fibroblast strains to survive after treatment with ultraviolet radiation indicates that their DNA repair defect is less severe than that of typical group A patients who have a more severe neurodegeneration with an earlier symptomatic onset. The premature death of nerve cells in XP patients (which is presumably due to their inherited defects in DNA repair mechanisms) suggests that normal repair of damaged DNA in neurons is required to maintain integrity of the human nervous system.

Entities:  

Mesh:

Year:  1991        PMID: 2065254     DOI: 10.1093/brain/114.3.1335

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  38 in total

1.  Real-time quantification of Xeroderma pigmentosum mRNA from the mammalian cochlea.

Authors:  O'neil W Guthrie; Franklin A Carrero-Martínez
Journal:  Ear Hear       Date:  2010-10       Impact factor: 3.570

2.  In vitro repair of oxidative DNA damage by human nucleotide excision repair system: possible explanation for neurodegeneration in xeroderma pigmentosum patients.

Authors:  J T Reardon; T Bessho; H C Kung; P H Bolton; A Sancar
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

3.  Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterises the role of DNA repair.

Authors:  Porcia T Bradford; Alisa M Goldstein; Deborah Tamura; Sikandar G Khan; Takahiro Ueda; Jennifer Boyle; Kyu-Seon Oh; Kyoko Imoto; Hiroki Inui; Shin-Ichi Moriwaki; Steffen Emmert; Kristen M Pike; Arati Raziuddin; Teri M Plona; John J DiGiovanna; Margaret A Tucker; Kenneth H Kraemer
Journal:  J Med Genet       Date:  2010-11-19       Impact factor: 6.318

Review 4.  Nucleotide excision repair deficient mouse models and neurological disease.

Authors:  Laura J Niedernhofer
Journal:  DNA Repair (Amst)       Date:  2008-02-12

Review 5.  Xeroderma pigmentosum, trichothiodystrophy and Cockayne syndrome: a complex genotype-phenotype relationship.

Authors:  K H Kraemer; N J Patronas; R Schiffmann; B P Brooks; D Tamura; J J DiGiovanna
Journal:  Neuroscience       Date:  2007-02-01       Impact factor: 3.590

Review 6.  Ophthalmic manifestations and histopathology of xeroderma pigmentosum: two clinicopathological cases and a review of the literature.

Authors:  Hema L Ramkumar; Brian P Brooks; Xiaoguang Cao; Deborah Tamura; John J Digiovanna; Kenneth H Kraemer; Chi-Chao Chan
Journal:  Surv Ophthalmol       Date:  2011 Jul-Aug       Impact factor: 6.048

7.  XPC initiation codon mutation in xeroderma pigmentosum patients with and without neurological symptoms.

Authors:  Sikandar G Khan; Kyu-Seon Oh; Steffen Emmert; Kyoko Imoto; Deborah Tamura; John J Digiovanna; Tala Shahlavi; Najealicka Armstrong; Carl C Baker; Marcy Neuburg; Chris Zalewski; Carmen Brewer; Edythe Wiggs; Raphael Schiffmann; Kenneth H Kraemer
Journal:  DNA Repair (Amst)       Date:  2008-11-14

8.  Clinical heterogeneity within xeroderma pigmentosum associated with mutations in the DNA repair and transcription gene ERCC3.

Authors:  W Vermeulen; R J Scott; S Rodgers; H J Müller; J Cole; C F Arlett; W J Kleijer; D Bootsma; J H Hoeijmakers; G Weeda
Journal:  Am J Hum Genet       Date:  1994-02       Impact factor: 11.025

9.  Fluorescent light-induced chromatid breaks distinguish Alzheimer disease cells from normal cells in tissue culture.

Authors:  R P Parshad; K K Sanford; F M Price; L K Melnick; L E Nee; M B Schapiro; R E Tarone; J H Robbins
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

10.  Mislocalization of XPF-ERCC1 nuclease contributes to reduced DNA repair in XP-F patients.

Authors:  Anwaar Ahmad; Jacqueline H Enzlin; Nikhil R Bhagwat; Nils Wijgers; Anja Raams; Esther Appledoorn; Arjan F Theil; Jan H J Hoeijmakers; Wim Vermeulen; Nicolaas G J Jaspers; Orlando D Schärer; Laura J Niedernhofer
Journal:  PLoS Genet       Date:  2010-03-05       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.